LIFESTYLE DELIVERY : Rêveur Live Resin Distributed to Multiple Retail Locations in California

DGAP-News: Lifestyle Delivery Systems Inc. / Key word(s): Product Launch/Market launch Rêveur Live Resin Distributed to Multiple Retail Locations in California 30.01.2019 / 14:15 The issuer is solely responsible for the content of this announcement. Rêveur Live Resin Distributed to Multiple Retail Locations in California Vancouver, British Columbia, Canada, January 30, 2019, Lifestyle Delivery Systems Inc. (CSE: LDS), (OTCQX: LDSYF), (Frankfurt: LD6, WKN: A14XHT) ("LDS" or the "Company") is pleased to announce that CSPA Group Inc.'s partnership with Rise Distribution ("Rise") is rapidly gaining momentum. Within the first week of receiving the Rêveur live resin products Rise has delivered Rêveur to the following new dispensaries: - Ganja Goddess - Panorama City (Los Angeles) - Exhale Med Center - West Hollywood - Bay Care Delivery - San Francisco - Bloom Room - San Francisco - Diamond Bonsai - Oakland - Los Angeles Valley Caregivers (LAVC)- Los Angeles - March and Ash - San Diego The distribution agreement with Rise provides the Company with a direct access to Rise's extensive state-wide retail network. Since entering into the distribution agreement, both companies have been working closely on creating and implementing highly efficient sales channels that will ensure rapid product distribution. Additionally, CSPA provided detailed product training to Rise's sales and product consultants ensuring a positive customer experience. Lifestyle Delivery Systems Inc.'s CEO, Brad Eckenweiler, stated, "We are extremely pleased to be expanding our product reach with Rise Distribution. Offering our Rêveur live resin products in these new retail locations paves the way for the seamless introduction of our flagship product, CannaStripsTM. The Rise agreement brings our products to multiple locations through Rise's expansive retail network providing purchasing convenience to our customers." CSPA Group's marketing director, Casey Fenwick, stated, "This agreement allows both companies to work to each other's strengths to benefit customers throughout California. Rise focuses on the logistics of efficiently delivering our products to their 200+ retailers enabling LDS to focus on our strength of producing innovative and affordable products at our industry leading facility." About Lifestyle Delivery Systems Inc. Lifestyle Delivery Systems Inc. is a technology company that licenses its technology to a state-of-the-art production and packaging facility located in Southern California. The Company's technology produces infused strips (similar to breath strips) that are not only a safer, healthier option to other forms of delivery but also superior bioavailability of cannabis constituents. Some strips will also include supplemental co-active ingredients such as nutraceuticals, vitamins and peptides. The technology provides a new way to accurately meter the dosage and assure the purity of selected product. From start to finish, the production process, based on the Company's technology, tests for quality and composition of all the ingredients used in each and every strip which results in a delivery system that is safe, consistent and effective. Lifestyle Delivery Systems Inc. Brad Eckenweiler CEO & Director Lifestyle Delivery Systems Inc. Suite 820, 1130 W. Pender St. Vancouver BC, V6E 4A4 T: [phone] F: [phone] CSE : LDS OTCQB : LDSYF Frankfurt: LD6, WKN: A14XHT www.lifestyledeliverysystem.com FOR MORE INFORMATION, PLEASE CONTACT: [e-mail] Cautionary Disclaimer Statement: The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release. Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management's current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. The Company cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company's control. Such factors include, among other things: risks and uncertainties relating to the Company's limited operating history and the need to comply with environmental and governmental regulations. In addition, marijuana remains a Schedule I drug under the United States Controlled Substances Act of 1970. Although Congress has prohibited the US Justice Department from spending federal funds to interfere with the implementation of state medical marijuana laws, this prohibition must be renewed each year to remain in effect. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward looking information. Except as required under applicable securities legislation, The Company undertakes no obligation to publicly update or revise forward-looking information. 30.01.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

770853  30.01.2019